Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Elevance Health ( (ELV) ) has shared an announcement.
Elevance Health, Inc. has announced that its officers will engage with investors to reaffirm the company’s earnings guidance for the full year 2025. The company expects earnings to be approximately $24.70 per diluted share, including $5.30 per share of net unfavorable items, and adjusted earnings to be around $30.00 per diluted share. Additionally, the benefit expense ratio is anticipated to be approximately 90.0%. These projections are based on current market conditions and operational performance, but actual results may vary if business factors or assumptions change.
The most recent analyst rating on (ELV) stock is a Buy with a $400.00 price target. To see the full list of analyst forecasts on Elevance Health stock, see the ELV Stock Forecast page.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Neutral.
Elevance Health’s overall stock score reflects strong financial performance and reasonable valuation, offset by operational challenges and cautious earnings guidance. The company’s robust revenue growth and stable balance sheet are significant strengths, but pressures in the ACA and Medicaid markets pose risks to future profitability.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
Average Trading Volume: 1,933,145
Technical Sentiment Signal: Sell
Current Market Cap: $70.62B
Learn more about ELV stock on TipRanks’ Stock Analysis page.